Transdiagnostic Oncology Program in Primary Care (TOP)

Lentis Psychiatric Institute

Status: Completed

Conditions: Cancer Survivor

Treatments: Behavioral: Transdiagnostic Oncologic Program

Study type: Observational

Funder types: Other

Identifiers

NCT06809452

M17.218911_TOP2

Details and patient eligibility

About

The goal of this observational study is to learn about how cancer survivors experience a relatively new 12-month interdisciplinary aftercare program called the Transdiagnostic Oncologic Program (TOP). TOP is an innovative program offered as part of routine family-doctor care among several practices in the province Drenthe, the Netherlands. It is coordinated by the family doctor and caried out by an interdisciplinary team, consisting of the family doctor, a physiotherapist, nutritionist, and optionally a psychologist. The main questions this study aims to answer are:

• Is TOP feasible and acceptable?
• Does TOP lead to improvements in quality of life in cancer survivors? Patients who were eligible for the program (n=54) were asked to participate in research as well. Everyone who participated in TOP (n=19) agreed to participate in this study as well. Those who declined participation (n=35), were asked to serve as controls, of which 16 agreed to do so.

Enrollment: 35 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Eligibility criteria for the program and for the study were the same, with the exception that participants were willing to sign informed consent to participate in the study.

Inclusion criteria:

• being between ≥18 and ≤ 75 years old
• having been diagnosed with cancer at least 6 months ago and/or have been long-term stable.

Exclusion criteria:

• having severe physical risks due to cancer treatment and / or comorbidities
• currently undergoing intensive chemotherapy or other treatment
• having cognitive or psychosomatic complaints that interfere with successful participation
• having skin cancer, except for melanomas with metastasis
• having a life expectancy of <1 year

Trial design

35 participants in 2 patient groups

Cancer survivors taking part in the program

Description:

Eligble cancer survivors who agreed to take part in TOP and in the study.

Treatment:

Behavioral: Transdiagnostic Oncologic Program

Cancer survivors serving as controls

Description:

Eligble cancer survivors who declined to take part in TOP, but agreed to take part in the study. They serve as a convenience control group.